Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03613493 · ClinicalTrials.gov registry record · NA
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 175
- Enrollment target
NCT03613493 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 175 participants.
The verdict
NCT03613493, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
Study Summary
The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.
Interventions
- BEHAVIORAL Interview
- DIAGNOSTIC_TEST HPV self-sampling kit
- BEHAVIORAL Culturally-targeted Fear Appeal Message
- BEHAVIORAL Fear Appeal Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2018-07-10 |
| Est. Completion | 2018-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03613493
The ClinicalTrials.gov registry entry for NCT03613493 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Interview is the first listed.
NCT03613493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03613493 about?
NCT03613493 is a clinical study titled "Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention". The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.
What is the current status of trial NCT03613493?
This trial is currently terminated. It is a NA study. The enrollment target is 175 participants. The study started on 2018-07-10. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT03613493?
The interventions under investigation include: Interview (BEHAVIORAL), HPV self-sampling kit (DIAGNOSTIC_TEST), Culturally-targeted Fear Appeal Message (BEHAVIORAL), Fear Appeal Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT03613493?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.